Recruiting NCT06830590
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Molecular characterisation.
- Who it may be relevant to
- Registry conditions: Breast Cancer, Molecular Pathway Deregulation, Treatment. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Pakistan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC
Interventions
- Procedure Molecular characterisation
All patients treated by surgery were included without any neoadjuvant therapy
Primary outcome measures
- Breast cancer specific survival in correlation with molecular pattern [Time frame: 10 years]
Eligibility criteria
Inclusion criteria
- Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC
Exclusion criteria
- patients received pre-operative chemotherapy or radiotherapy
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Pakistan · 1 center
- Binafsha M Syed — Jamshoro
Identifiers
NCT: NCT06830590 · BreastCa001